Revelation Biosciences's total assets for Q4 2025 were $11.58M, a decrease of -9.90% from the previous quarter. REVB total liabilities were $2.72M for the fiscal quarter, a 46.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.